SEC Form 4 · accession 0001615774-17-003462
Tonix Pharmaceuticals Holding Corp. · TNXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernest Mario
Director
Period of report
Jun 30, 2017
Accepted (ET)
Jun 30, 2017 · 8:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001430306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1 | Jun 30, 2017 | S | 6,105 | $4.278 | D | 5,895 | I | By Ernest and Mildred Mario Revocable Trust |
| Common Stock, $0.001 par value | holding | — | — | — | 63,073 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $4.327801965601966. The range of sale prices on the transaction date was $4.25 to $4.29 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.